{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:37:54Z","timestamp":1790714274645,"version":"4.1.0"},"reference-count":142,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1053\/j.semnuclmed.2003.09.007","type":"journal-article","created":{"date-parts":[[2005,2,10]],"date-time":"2005-02-10T02:50:47Z","timestamp":1108003847000},"page":"56-69","source":"Crossref","is-referenced-by-count":55,"title":["Implications of PET based molecular imaging on the current and future practice of medicine"],"prefix":"10.1053","volume":"34","author":[{"given":"Abass","family":"Alavi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin W","family":"Kung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongming","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2214\/ajr.131.1.51","article-title":"Comparison of computed and conventional whole lung tomography in detecting pulmonary nodules","volume":"131","author":"Schaner","year":"1978","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2214\/ajr.143.3.519","article-title":"Pulmonary evaluation of patients with osteosarcoma","volume":"143","author":"Vanel","year":"1984","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB3","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2214\/ajr.131.6.981","article-title":"Comparison of whole lung tomography and computed tomography for detecting pulmonary nodules","volume":"131","author":"Muhm","year":"1978","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/107110078901000101","article-title":"Magnetic resonance imaging of the hindfoot","volume":"10","author":"Crim","year":"1989","journal-title":"Foot & Ankle"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB5","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2214\/ajr.146.6.1167","article-title":"MRI of hemorrhagic renal cysts in polycystic kidney disease","volume":"146","author":"Hilpert","year":"1986","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/jmri.1880040316","article-title":"Solitary hepatic metastasis","volume":"4","author":"Semelka","year":"1994","journal-title":"J Magn Reson Imaging"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1148\/radiology.165.2.3310094","article-title":"Hepatic metastases","volume":"165","author":"Stark","year":"1987","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.med.53.082901.104028","article-title":"Positron emission tomography scanning","volume":"53","author":"Czernin","year":"2002","journal-title":"Annu Rev Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB9","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1161\/01.STR.0000071761.36075.A6","article-title":"Functional neuroimaging studies of motor recovery after stroke in adults","volume":"34","author":"Calautti","year":"2003","journal-title":"Stroke"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s00261-001-0183-8","article-title":"Functional MRI of the kidney","volume":"28","author":"Grenier","year":"2003","journal-title":"Abdom Imaging"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/bcr269","article-title":"Probing physiology and molecular function using optical imaging","volume":"3","author":"Ntziachristos","year":"2001","journal-title":"Breast Cancer Res"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00330-002-1524-x","article-title":"Fluorescence imaging with near-infrared light","volume":"13","author":"Ntziachristos","year":"2003","journal-title":"Eur Radiol"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB13","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s002590050283","article-title":"Design of hypoxia-targeting radiopharmaceuticals","volume":"25","author":"Dearling","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/snuc.2002.29269","article-title":"The conception of FDG-PET imaging","volume":"32","author":"Alavi","year":"2002","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0001-2998(05)80079-0","article-title":"Studies of central nervous system disorders with single photon emission computed tomography and positron emission tomography","volume":"21","author":"Alavi","year":"1991","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB16","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0969-8051(99)00021-9","article-title":"Assays for noninvasive imaging of reporter gene expression","volume":"26","author":"Gambhir","year":"1999","journal-title":"Nucl Med Biol"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB17","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1177\/00912700122010357","article-title":"Fundamentals of positron emission tomography and applications in preclinical drug development","volume":"41","author":"Cherry","year":"2001","journal-title":"J Clin Pharmacol"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB18","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3109\/07853899908998801","article-title":"Drug development, radiolabelled drugs and PET","volume":"31","author":"Vaalburg","year":"1999","journal-title":"Ann Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1053\/snuc.2002.29276","article-title":"Determination of regional cerebral function with FDG-PET imaging in neuropsychiatric disorders","volume":"32","author":"Newberg","year":"2002","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB20","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1212\/WNL.33.4.400","article-title":"Local cerebral metabolism during partial seizures","volume":"33","author":"Engel","year":"1983","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB21","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ana.410140406","article-title":"[18F]fluorodeoxyglucose positron emission tomography in refractory complex partial seizures","volume":"14","author":"Theodore","year":"1983","journal-title":"Ann Neurol"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB22","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1528-1157.1998.tb01162.x","article-title":"Clinical value of \u201cictal\u201d FDG-positron emission tomography and the routine use of simultaneous scalp EEG studies in patients with intractable partial epilepsies","volume":"39","author":"Barrington","year":"1998","journal-title":"Epilepsia"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/brain\/124.1.167","article-title":"Extrahippocampal temporal lobe atrophy in temporal lobe epilepsy and mesial temporal sclerosis","volume":"124","author":"Moran","year":"2001","journal-title":"Brain"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1212\/WNL.60.3.405","article-title":"Hippocampal atrophy and T2-weighted signal changes in familial mesial temporal lobe epilepsy","volume":"60","author":"Kobayashi","year":"2003","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB25","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s002590100602","article-title":"Inter-modality comparisons of seizure focus lateralization in complex partial seizures","volume":"28","author":"Meyer","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB26","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1212\/WNL.52.4.700","article-title":"Efficacy and safety of eptastigmine for the treatment of patients with Alzheimer\u2019s disease","volume":"52","author":"Imbimbo","year":"1999","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB27","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1212\/WNL.50.5.1222","article-title":"Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer\u2019s disease","volume":"50","author":"Morris","year":"1998","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB28","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/jama.1994.03510370037029","article-title":"A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer\u2019s disease. The Tacrine Study Group","volume":"271","author":"Knapp","year":"1994","journal-title":"JAMA"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB29","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1212\/WNL.50.1.136","article-title":"A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer\u2019s disease. Donepezil Study Group","volume":"50","author":"Rogers","year":"1998","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB30","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/bmj.318.7184.633","article-title":"Efficacy and safety of rivastigmine in patients with Alzheimer\u2019s disease","volume":"318","author":"Rosler","year":"1999","journal-title":"BMJ"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB31","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/ana.410150504","article-title":"Patterns of local cerebral glucose utilization determined in Parkinson\u2019s disease by the [18F]fluorodeoxyglucose method","volume":"15","author":"Kuhl","year":"1984","journal-title":"Ann Neurol"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB32","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/BF02988628","article-title":"Clinical application of positron emission tomography for diagnosis of dementia","volume":"16","author":"Ishii","year":"2002","journal-title":"Ann Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB33","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0001-2998(86)80002-2","article-title":"Positron emission tomography imaging of regional cerebral glucose metabolism","volume":"16","author":"Alavi","year":"1986","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB34","first-page":"391","article-title":"Differential diagnosis of Alzheimer\u2019s disease with PET","volume":"35","author":"Salmon","year":"1994","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1053\/snuc.2003.127294","article-title":"Positron emission tomography and single-photon emission computed tomography brain imaging in the evaluation of dementia","volume":"33","author":"Van Heertum","year":"2003","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB36","first-page":"1363","article-title":"Cerebral ischemia and Alzheimer\u2019s disease","volume":"39","author":"Alavi","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB37","first-page":"1681","article-title":"Quantitative analysis of PET and MRI data in normal aging and Alzheimer\u2019s disease","volume":"34","author":"Alavi","year":"1993","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB38","first-page":"855","article-title":"Initial human PET imaging studies with the dopamine transporter ligand 18F-FECNT","volume":"44","author":"Davis","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB39","first-page":"421","article-title":"Reproducibility and discriminating ability of fluorine-18-6-fluoro-L-Dopa PET in Parkinson\u2019s disease","volume":"37","author":"Vingerhoets","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB40","first-page":"999","article-title":"Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson\u2019s disease patients","volume":"44","author":"Huang","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB41","first-page":"1170","article-title":"AMetabolic consequences of acute brain trauma","volume":"37","author":"Alavi","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB42","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1053\/snuc.2003.127299","article-title":"Neuroimaging in patients with head injury","volume":"33","author":"Newberg","year":"2003","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB43","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00003072-200307000-00006","article-title":"A metabolic imaging severity rating scale for the assessment of cognitive impairment","volume":"28","author":"Newberg","year":"2003","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB44","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1001\/jama.286.17.2120","article-title":"Positron emission tomography in evaluation of dementia","volume":"286","author":"Silverman","year":"2001","journal-title":"JAMA"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB45","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM198702123160701","article-title":"Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington\u2019s disease","volume":"316","author":"Mazziotta","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB46","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.410120504","article-title":"Cerebral metabolism and atrophy in Huntington\u2019s disease determined by 18FDG and computed tomographic scan","volume":"12","author":"Kuhl","year":"1982","journal-title":"Ann Neurol"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB47","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0165-1781(89)90090-5","article-title":"Cerebral glucose consumption measured by PET in patients with and without psychiatric symptoms of Huntington\u2019s disease","volume":"29","author":"Kuwert","year":"1989","journal-title":"Psychiatry Res"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/snuc.2002.29272","article-title":"Whole-body FDG-PET imaging in the management of patients with cancer","volume":"32","author":"Hustinx","year":"2002","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB49","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1148\/radiology.193.3.7972793","article-title":"Proceedings of a National Cancer Institute workshop","volume":"193","author":"Wahl","year":"1994","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB50","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/BF01249629","article-title":"Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose","volume":"23","author":"Rigo","year":"1996","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB51","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1053\/snuc.2000.7439","article-title":"PET imaging in oncology","volume":"30","author":"Bar-Shalom","year":"2000","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB52","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/BF01731846","article-title":"Staging of non-small-cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomography","volume":"23","author":"Bury","year":"1996","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB53","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1055\/s-2007-1013107","article-title":"Improvement of non-small-cell lung cancer staging by means of positron emission tomography","volume":"47","author":"Albes","year":"1999","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB54","first-page":"814","article-title":"PET in lung cancer","volume":"40","author":"Coleman","year":"1999","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB55","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/sroe.2001.25126","article-title":"Current status of PET in breast cancer imaging, staging, and therapy","volume":"36","author":"Wahl","year":"2001","journal-title":"Semin Roentgenol"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB56","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/00006231-200009000-00002","article-title":"The role of positron emission tomography with fluorine-18-deoxyglucose in identifying colorectal cancer metastases to liver","volume":"21","author":"Zhuang","year":"2000","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB57","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1055\/s-2007-996906","article-title":"[F-18 FDG PET for detection of occult primary tumor in patients with lymphatic metastases of the neck region]","volume":"78","author":"Bohuslavizki","year":"1999","journal-title":"Laryngorhinootologie"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB58","first-page":"816","article-title":"FDG PET detection of unknown primary tumors","volume":"41","author":"Bohuslavizki","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB59","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0901-5027(05)80829-X","article-title":"Detection of unknown primary head and neck tumors by positron emission tomography","volume":"26","author":"Braams","year":"1997","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB60","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0959-8049(99)00077-5","article-title":"18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT)","volume":"35","author":"Lassen","year":"1999","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB61","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1160::AID-CNCR22>3.0.CO;2-3","article-title":"Detection of unknown occult primary tumors using positron emission tomography","volume":"82","author":"Kole","year":"1998","journal-title":"Cancer"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB62","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s002590050593","article-title":"Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography","volume":"26","author":"Hustinx","year":"1999","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB63","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2214\/ajr.169.6.9393187","article-title":"FDG PET in head and neck cancer","volume":"169","author":"Keyes","year":"1997","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB64","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00277-001-0390-y","article-title":"Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin\u2019s disease","volume":"81","author":"Weihrauch","year":"2002","journal-title":"Ann Hematol"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB65","first-page":"1196","article-title":"Staging recurrent metastatic colorectal carcinoma with PET","volume":"38","author":"Delbeke","year":"1997","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB66","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0959-8049(01)00049-1","article-title":"Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer","volume":"37","author":"Flamen","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB67","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00000658-199803000-00001","article-title":"Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer","volume":"227","author":"Flanagan","year":"1998","journal-title":"Ann Surg"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB68","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/BF02055166","article-title":"Fluorodeoxyglucose whole-body positron emission tomography in colorectal cancer patients studied in routine daily practice","volume":"40","author":"Ruhlmann","year":"1997","journal-title":"Dis Colon Rectum"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB69","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/archsurg.134.5.503","article-title":"Whole-body PET imaging with [18F]fluorodeoxyglucose in management of recurrent colorectal cancer","volume":"134","author":"Valk","year":"1999","journal-title":"Arch Surg"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB70","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jama.1993.03510080047030","article-title":"An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer","volume":"270","author":"Moertel","year":"1993","journal-title":"JAMA"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB71","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0002-9610(99)80067-1","article-title":"Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver","volume":"171","author":"Vitola","year":"1996","journal-title":"Am J Surg"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB72","first-page":"4464","article-title":"Positron emission tomography in non-Hodgkin\u2019s lymphoma","volume":"91","author":"Romer","year":"1998","journal-title":"Blood"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB73","first-page":"1018","article-title":"PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin\u2019s disease","volume":"43","author":"Kostakoglu","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB74","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s002590050275","article-title":"Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma","volume":"25","author":"Stumpe","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB75","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1200\/JCO.2001.19.12.3058","article-title":"Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging","volume":"19","author":"Weber","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB76","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1200\/JCO.1996.14.3.700","article-title":"Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases","volume":"14","author":"Findlay","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB77","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJMoa020461","article-title":"Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors","volume":"347","author":"Demetri","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB78","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/snuc.2002.29278","article-title":"18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation","volume":"32","author":"Zhuang","year":"2002","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB79","first-page":"44","article-title":"The promising role of 18F-FDG PET in detecting infected lower limb prosthesis implants","volume":"42","author":"Zhuang","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB80","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00006231-200207000-00009","article-title":"The use of [18 F]fluorodeoxyglucose positron emission tomography to differentiate between synovitis, loosening and infection of hip and knee prostheses","volume":"23","author":"Manthey","year":"2002","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB81","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00259-002-1109-6","article-title":"The value of (18)FDG-PET for the detection of infected hip prosthesis","volume":"30","author":"Vanquickenborne","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB82","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00003072-200004000-00009","article-title":"Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging","volume":"25","author":"Zhuang","year":"2000","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB83","first-page":"2145","article-title":"Fluorine-18-FDG PET and technetium-99m antigranulocyte antibody scintigraphy in chronic osteomyelitis","volume":"39","author":"Guhlmann","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB84","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1086\/318480","article-title":"Clinical value of [(18)F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin","volume":"32","author":"Blockmans","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB85","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s002590000341","article-title":"Fever of unknown origin","volume":"27","author":"Meller","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB86","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/00006231-200107000-00009","article-title":"Value of FDG PET in patients with fever of unknown origin","volume":"22","author":"Lorenzen","year":"2001","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB87","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1111\/j.1572-0241.2002.05836.x","article-title":"Noninvasive assessment of Crohn\u2019s disease activity","volume":"97","author":"Neurath","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB88","first-page":"1650","article-title":"Is there a role for FDG PET imaging in the management of patients with sarcoidosis?","volume":"35","author":"Alavi","year":"1994","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB89","first-page":"1647","article-title":"Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis","volume":"35","author":"Lewis","year":"1994","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB90","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/01.RLU.0000053528.35645.70","article-title":"Unsuspected skeletal sarcoidosis mimicking metastatic disease on FDG positron emission tomography and bone scintigraphy","volume":"28","author":"Ludwig","year":"2003","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB91","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/00003072-199612000-00021","article-title":"High fluorine-18 labeled deoxyglucose uptake in sarcoidosis","volume":"21","author":"Yasuda","year":"1996","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB92","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/art.1780380616","article-title":"Use of magnetic resonance imaging and positron emission tomography in the assessment of synovial volume and glucose metabolism in patients with rheumatoid arthritis","volume":"38","author":"Polisson","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB93","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00004728-199901000-00004","article-title":"FDG-PET finding in early-phase Takayasu arteritis","volume":"23","author":"Hara","year":"1999","journal-title":"J Comput Assist Tomogr"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB94","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2143\/AC.55.3.2005739","article-title":"Positron emission tomography scan in the diagnosis and follow-up of aortitis of the thoracic aorta","volume":"55","author":"Derdelinckx","year":"2000","journal-title":"Acta Cardiol"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB95","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/rheumatology\/38.5.444","article-title":"New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography","volume":"38","author":"Blockmans","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB96","first-page":"1701","article-title":"Coronary flow and flow reserve by PET simplified for clinical applications using rubidium-82 or nitrogen-13-ammonia","volume":"37","author":"Yoshida","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB97","first-page":"1426","article-title":"Detection of serial changes in absolute myocardial perfusion with 82Rb PET","volume":"41","author":"deKemp","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB98","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/snuc.2002.29279","article-title":"18F FDG uptake in the large arteries","volume":"32","author":"Yun","year":"2002","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB99","first-page":"38","article-title":"Imaging atherosclerotic macrophage density by positron emission tomography using F-18-fluorodeoxyglucose","volume":"37","author":"Vallabhajosula","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB100","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/snuc.2001.18742","article-title":"Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate","volume":"31","author":"Blake","year":"2001","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB101","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3109\/02841869609084008","article-title":"Kinetics of [methyl-11C]thymidine in patients with squamous cell carcinoma of the head and neck","volume":"35","author":"van Eijkeren","year":"1996","journal-title":"Acta Oncol"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB102","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0883-2889(91)90131-J","article-title":"Production of [2\u201311C]thymidine for quantification of cellular proliferation with PET","volume":"42","author":"Vander Borght","year":"1991","journal-title":"Int J Rad Appl Instrum [A]"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB103","first-page":"3791","article-title":"3\u2032-deoxy-3\u2032-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography","volume":"63","author":"Barthel","year":"2003","journal-title":"Cancer Res"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB104","first-page":"3331","article-title":"3-deoxy-3-[(18)F]fluorothymidine-positron emission tomography for noninvasive assessment of proliferation in pulmonary nodules","volume":"62","author":"Buck","year":"2002","journal-title":"Cancer Res"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB105","first-page":"2681","article-title":"3\u2032-[18F]fluoro-3\u2032-deoxythymidine ([18F]-FLT) as positron emission tomography tracer for imaging proliferation in a murine B-Cell lymphoma model and in the human disease","volume":"63","author":"Wagner","year":"2003","journal-title":"Cancer Res"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB106","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/3337","article-title":"Imaging proliferation in vivo with [F-18]FLT and positron emission tomography","volume":"4","author":"Shields","year":"1998","journal-title":"Nat Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB107","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0360-3016(95)00170-4","article-title":"Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography","volume":"33","author":"Koh","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB108","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF01081524","article-title":"Nitroimidazoles and imaging hypoxia","volume":"22","author":"Nunn","year":"1995","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB109","first-page":"1155","article-title":"Copper-62-ATSM","volume":"38","author":"Fujibayashi","year":"1997","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB110","first-page":"327","article-title":"Noninvasive detection of tumor hypoxia using the 2-nitroimidazole [18F]EF1","volume":"41","author":"Evans","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB111","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0969-8043(00)00102-0","article-title":"[18F]-EF5, a marker for PET detection of hypoxia","volume":"54","author":"Dolbier","year":"2001","journal-title":"Appl Radiat Isot"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB112","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/jmri.10171","article-title":"Nuclear medicine applications in molecular imaging","volume":"16","author":"Blankenberg","year":"2002","journal-title":"J Magn Reson Imaging"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB113","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1172\/JCI6869","article-title":"The role of alpha-v integrins during angiogenesis","volume":"103","author":"Eliceiri","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB114","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF00046839","article-title":"Structure, function and biological properties of integrin alpha v beta 3 on human melanoma cells","volume":"10","author":"Cheresh","year":"1991","journal-title":"Cancer Metastasis Rev"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB115","first-page":"1781","article-title":"Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography","volume":"61","author":"Haubner","year":"2001","journal-title":"Cancer Res"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB116","first-page":"326","article-title":"Glycosylated RGD-containing peptides","volume":"42","author":"Haubner","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB117","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1200\/JCO.2001.19.19.3918","article-title":"Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin\u2019s lymphomas","volume":"19","author":"Kaminski","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB118","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1200\/JCO.2002.11.076","article-title":"Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin\u2019s lymphoma","volume":"20","author":"Witzig","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB119","first-page":"1685","article-title":"Copper-64-labeled antibodies for PET imaging","volume":"33","author":"Anderson","year":"1992","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB120","first-page":"1053","article-title":"PET imaging of somatostatin receptors using","volume":"42","author":"Henze","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB121","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1148\/radiology.186.1.8380108","article-title":"Cerebral glioma","volume":"186","author":"Ogawa","year":"1993","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB122","first-page":"432","article-title":"Radiolabeled amino acids","volume":"42","author":"Jager","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB123","first-page":"990","article-title":"PET imaging of prostate cancer using carbon-11-choline","volume":"39","author":"Hara","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB124","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s002590000309","article-title":"Experience with carbon-11 choline positron emission tomography in prostate carcinoma","volume":"27","author":"Kotzerke","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB125","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0022-5347(05)64906-3","article-title":"Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer","volume":"168","author":"Price","year":"2002","journal-title":"J Urol"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB126","first-page":"556","article-title":"PET imaging of prostate cancer with 11C-acetate","volume":"44","author":"Dimitrakopoulou-Strauss","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB127","first-page":"181","article-title":"11C-acetate PET imaging of prostate cancer","volume":"43","author":"Oyama","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB128","first-page":"933","article-title":"Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer","volume":"2","author":"Mortimer","year":"1996","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB129","first-page":"1766","article-title":"Positron tomographic assessment of estrogen receptors in breast cancer","volume":"36","author":"Dehdashti","year":"1995","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB130","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrc882","article-title":"Molecular imaging of cancer with positron emission tomography","volume":"2","author":"Gambhir","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB131","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00003072-200103000-00016","article-title":"FDG uptake in chronic superior vena cava thrombus on positron emission tomographic imaging","volume":"26","author":"Lin","year":"2001","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB132","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/00003072-200010000-00026","article-title":"Detection of chronic recurrent lower extremity deep venous thrombosis on fluorine-18 fluorodeoxyglucose positron emission tomography","volume":"25","author":"Chang","year":"2000","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB133","first-page":"1412","article-title":"Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes","volume":"42","author":"Zhuang","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB134","first-page":"871","article-title":"Dual time point 18F-FDG PET for the evaluation of pulmonary nodules","volume":"43","author":"Matthies","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB135","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/0003-9861(84)90215-7","article-title":"Partial purification from human mononuclear cells and placental plasma membranes of an insulin mediator which stimulates pyruvate dehydrogenase and suppresses glucose-6-phosphatase","volume":"235","author":"Suzuki","year":"1984","journal-title":"Arch Biochem Biophys"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB136","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0969-8051(96)00037-6","article-title":"The interaction among glucose transport, hexokinase, and glucose-6-phosphatase with respect to 3H-2-deoxyglucose retention in murine tumor models","volume":"23","author":"Nelson","year":"1996","journal-title":"Nucl Med Biol"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB137","first-page":"1154","article-title":"Metabolic trapping as a principle of radiopharmaceutical design","volume":"19","author":"Gallagher","year":"1978","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB138","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1007\/s003300101007","article-title":"Combining anatomy and function","volume":"11","author":"Townsend","year":"2001","journal-title":"Eur Radiol"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB139","first-page":"533","article-title":"A combined PET\/CT scanner","volume":"42","author":"Townsend","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB140","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00259-002-1055-3","article-title":"PET-CT","volume":"30","author":"Cohade","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB141","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00006231-200304000-00003","article-title":"Positron emission and computed X-ray tomography","volume":"24","author":"Costa","year":"2003","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2003.09.007_BIB142","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1056\/NEJMoa022136","article-title":"Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography","volume":"348","author":"Lardinois","year":"2003","journal-title":"N Engl J Med"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299803000734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299803000734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T18:18:34Z","timestamp":1586110714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299803000734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":142,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0001299803000734"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2003.09.007","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}